DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/l34qd8/partnerships)
has announced the addition of the "Partnerships,
Licensing, Investments and M&A Deals and Trends for 09, 2013 in
Pharmaceuticals" report to their offering.
Partnerships,
Licensing, Investments and M&A Deals and Trends for September 2013 in
Pharmaceuticals report is an essential source of data and trend analysis
on partnerships, licensing, mergers and acquisitions (M&As) and
financings in the pharmaceuticals industry.
The report provides detailed information on partnership and licensing
transactions, M&As, equity/debt offerings, private equity, and venture
financing registered in the pharmaceuticals industry in September 2013.
The report portrays detailed comparative data on the number of deals and
their value in the last six months, subdivided by deal types, various
therapy areas, and geographies. Additionally, the report provides
information on the top financial advisory firms in the pharmaceuticals
industry.
Data presented in this report is derived from Our
proprietary in-house deals database and primary and secondary research.
Scope
-
Analysis of the market trends for the pharmaceutical industry in the
global arena.
- Review of deal trends in the cardiovascular, central nervous system,
dermatology, ear nose throat disorders, gastrointestinal, genito urinary
system and sex hormones, hematological disorders, hormonal disorders,
immunology, infectious disease, male health, metabolic disorders, mouth
and dental disorders, musculoskeletal, oncology, ophthalmology,
respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings,
private equity, and venture financing deals in the pharmaceutical
industry.
- Analysis of therapy areas which are very active in terms of venture
capital financing, partnerships, licensing agreements, equity/debt
offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront
and milestone payments, primarily in partnerships and licensing
agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of
development of products.
- Summary of the pharmaceutical deals globally in the last five quarters.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific,
South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings.
This includes key advisors such as Morgan Stanley, Credit Suisse, and
Goldman Sachs.
For more information visit http://www.researchandmarkets.com/research/l34qd8/partnerships
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
